Cargando…
Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification
According to the 2019 World Health Organization (WHO) classification, well-differentiated grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are a new category of cancer of the digestive system. G3 GEP-NET research and treatment are not as robust as those of lower grade (G1/2) NE...
Autores principales: | Xu, Jun-Xi, Wu, De-Hao, Ying, Li-Wei, Hu, Han-Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704278/ https://www.ncbi.nlm.nih.gov/pubmed/35068858 http://dx.doi.org/10.3748/wjg.v27.i47.8123 |
Ejemplares similares
-
Role of surgical treatments in high-grade or advanced gastroenteropancreatic neuroendocrine neoplasms
por: Que, Qing-Yang, et al.
Publicado: (2022) -
Current status of surgical management of patients with gastroenteropancreatic neuroendocrine neoplasms
por: Stankiewicz, Rafał, et al.
Publicado: (2022) -
Diagnosis, treatment, and current concepts in the endoscopic management of gastroenteropancreatic neuroendocrine neoplasms
por: Iabichino, Giuseppe, et al.
Publicado: (2022) -
Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumors
por: Grey, Neil, et al.
Publicado: (2022) -
Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors
por: Das, Satya, et al.
Publicado: (2021)